April 11, 2014 — The European Medicines Agency (EMA), the largest health regulatory agency in the European Union, will investigate the link between testosterone replacement therapy and cardiovascular side effects.
The EMA review of testosterone-containing medicines parallels a similar investigation by the U.S. Food and Drug Administration (FDA).
Health officials are concerned about two recent studies linking testosterone therapy to an increased risk of heart attack, stroke, and death. One study involving 56,000 men in the VA health system found that men over 65 on testosterone were twice as likely to have a heart attack than men who did not use testosterone. Even higher risks were seen for younger men with heart disease.
The EMA has asked manufacturers of testosterone products to provide clinical trial data on cardiovascular risks. Investigators also want marketing information.
The marketing of testosterone therapy is under scrutiny because prescriptions have skyrocketed among men who do not have hypogonadism (low testosterone). Testosterone levels naturally decline with age, and some older men are using it to boost energy, mood, sexual performance, and “pump up” muscles.
However, in most European countries and Australia where direct-to-consumer marketing is banned, sales of testosterone have risen only slightly — according to a study published in Medical Journal of Australia last year.
Do I have a Testosterone Treatment Lawsuit?
The Schmidt Firm, PLLC is currently accepting testosterone therapy induced injury cases in all 50 states. If you or somebody you know has been injured by a blood clot, heart attack, stroke, or wrongful death, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.